Insights into the mechanisms of action of host defence peptides from biophysical and structural investigations

Journal of Peptide Science

Volumn 17, Issue 5, 2011, Pages 306-314

  Bechinger, Burkhard ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Alamethicin; Cecropin; Equlibria; Hydrophobic mismatch; In plane orientation; Magainin; Membrane macroscopic phase; Membrane pore; Membrane topology; Peptaibol; Peptide lipid interactions; PGLa; Solid state NMR; Transmembrane alignment; Uniaxially oriented membranes

Indexed keywords

HISTIDINE; PEPTIDE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; CIRCULAR DICHROISM; DRUG MECHANISM; FLOCCULATION; LIPID COMPOSITION; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW;

CECROPINS; CELL MEMBRANE; MAGAININS; MAGNETIC RESONANCE SPECTROSCOPY; PEPTAIBOLS; PEPTIDES;

EID: 79953805263     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1343     Document Type: Review

References (133)

1. Vooturi SK, Firestine SM. Synthetic membrane-targeted antibiotics. Curr. Med. Chem. 2010; 17: 2292-2300.
2. Savjani JK, Gajjar AK, Savjani KT. Mechanisms of resistance: useful tool to design antibacterial agents for drug-resistant bacteria. Mini. Rev. Med. Chem. 2009; 9: 194-205.
3. Benko-Iseppon AM, Galdino SL, Calsa T Jr, Kido EA, Tossi A, Belarmino LC, Crovella S. Overview on plant antimicrobial peptides. Curr. Protein Pept. Sci. 2010; 11: 181-188.
4. Padovan L, Scocchi M, Tossi A. Structural aspects of plant antimicrobial peptides. Curr. Protein Pept. Sci. 2010; 11: 210-219.
5. Bulet P, Stocklin R, Menin L. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 2004; 198: 169-184.
6. Reddy KV, Yedery RD, Aranha C. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents. 2004; 24: 536-547.
7. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002; 415: 389-395.
8. Boman HG. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 2003; 254: 197-215.
9. Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 2009; 15: 2377-2392.
10. Steinstraesser L, Kraneburg U, Jacobsen F, Al-Benna S. Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology. 2010; doi:10.1016/j.imbio.2010.07.003.
11. Holzl MA, Hofer J, Steinberger P, Pfistershammer K, Zlabinger GJ. Host antimicrobial proteins as endogenous immunomodulators. Immunol. Lett. 2008; 119: 4-11.
12. Kindrachuk J, Napper S. Structure-activity relationships of multifunctional host defence peptides. Mini. Rev. Med. Chem. 2010; 10: 596-614.
13. Liu SP, Zhou L, Lakshminarayanan R, Beuerman RW. Multivalent antimicrobial peptides as therapeutics: design principles and structural diversities. Int. J. Pept. Res. Ther. 2010; 16: 199-213.
14. Hadley EB, Hancock RE. Strategies for the discovery and advancement of novel cationic antimicrobial peptides. Curr. Top. Med. Chem. 2010; 10: 1872-1881.
15. Schweizer F. Cationic amphiphilic peptides with cancer-selective toxicity. Eur. J. Pharmacol. 2009; 625: 190-194.
16. Oyston PC, Fox MA, Richards SJ, Clark GC. Novel peptide therapeutics for treatment of infections. J. Med. Microbiol. 2009; 58: 977-987.
17. Bechinger B. Structure and functions of channel-forming polypeptides: magainins, cecropins, melittin and alamethicin. J. Membr. Biol. 1997; 156: 197-211.
18. Hwang PM, Vogel HJ. Structure-function relationships of antimicrobial peptides. Biochem. Cell. Biol. 1998; 76: 235-246.
19. Duclohier H. Antimicrobial peptides and peptaibols, substitutes for conventional antibiotics. Curr. Pharm. Des. 2010; 16: 3212-3223.
20. Haney EF, Hunter HN, Matsuzaki K, Vogel HJ. Solution NMR studies of amphibian antimicrobial peptides: linking structure to function?. Biochim. Biophys. Acta 2009; 1788: 1639-1655.
21. Gregory SM, Cavenaugh A, Journigan V, Pokorny A, Almeida PFF. A quantitative model for the all-or-none permeabilization of phospholipid vesicles by the antimicrobial peptide cecropin A. Biophys. J. 2008; 94: 1667-1680.
22. Kiss G, Michl H. öber das Giftsekret der Gelbbauchunke Bombina variegata L. Toxicon (Oxford) 1962; 1: 33-39.
23. Hoffmann W, Richter K, Kreil G. A novel peptide designated PYL abd its precursor as predicted from cloned mRNA of Xenopus laevis skin. EMBO J. 1983; 2: 711-714.
24. Giovannini MG, Poulter L, Gibson BW, Williams DH. Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones. Biochem. J. 1987; 243: 113-120.
25. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U S A 1987; 84: 5449-5453.
26. Boman HG, Hultmark D. Cell-free immunity in insects. Ann. Rev. Microbiol. 1987; 41: 103-126.
27. Dennison SR, Whittaker M, Harris F, Phoenix DA. Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes. Curr. Protein Pept. Sci. 2006; 7: 487-499.
28. Mader JS, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin. Investig. Drugs. 2006; 15: 933-946.
29. Zairi A, Tangy F, Bouassida K, Hani K. Dermaseptins and magainins: antimicrobial peptides from frogs' skin-new sources for a promising spermicides microbicides-a mini review. J. Biomed. Biotechnol. 2009; 2009: 452567.
30. Zhang L, Falla TJ. Potential therapeutic application of host defense peptides. Methods. Mol. Biol. 2010; 618: 303-327.
31. Giuliani A, Pirri G, Bozzi A, Di Giulio A, Aschi M, Rinaldi AC. Antimicrobial peptides: natural templates for synthetic membrane-active compounds. Cell. Mol. Life. Sci. 2008; 65: 2450-2460.
32. Fernandez DI, Gehman JD, Separovic F. Membrane interactions of antimicrobial peptides from Australian frogs. Biochim. Biophys. Acta 2009; 1788: 1630-1638.
33. Beevers AJ, Dixon AM. Helical membrane peptides to modulate cell function. Chem. Soc. Rev. 2010; 39: 2146-2157.
34. Gottler LM, Ramamoorthy A. Structure, membrane orientation, mechanism, and function of pexiganan-a highly potent antimicrobial peptide designed from magainin. Biochim. Biophys. Acta 2009; 1788: 1680-1686.
35. Georgescu J, Bechinger B. NMR structures of the histidine-rich peptide LAH4 in micellar environments: membrane insertion, pH-dependent mode of antimicrobial action and DNA transfection. Biophys. J. 2010; 99: 2507-2515.
36. Bolintineanu D, Hazrati E, Davis HT, Lehrer RI, Kaznessis YN. Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli. Peptides. 2010; 31: 1-8.
37. Pieters RJ, Arnusch CJ, Breukink E. Membrane permeabilization by multivalent anti-microbial peptides. Protein Pept. Lett. 2009; 16: 736-742.
38. Hugosson M, Andreu D, Boman HG, Glaser E. Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import. Eur. J. Biochem. 1994; 223: 1027-1033.
39. Westerhoff HV, Juretic D, Hendler RW, Zasloff M. Magainins and the disruption of membrane-linked free-energy transduction. Proc. Natl. Acad. Sci. U S A 1989; 86: 6597-6601.
40. Wade D, Boman A, Wahlin B, Drain CM, Andreu D, Boman HG, Merrifield RB. All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. U S A 1990; 87: 4761-4765.
41. Bechinger B. The structure, dynamics and orientation of antimicrobial peptides in membranes by solid-state NMR spectroscopy. Biochim. Biophys. Acta 1999; 1462: 157-183.
42. Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW. Membrane pores induced by magainin. Biochemistry 1996; 35: 13723-13728.
43. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1998; 1376: 391-400.
44. Shai Y. Mechanism of the binding, insertion, and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective lytic peptides. Biochim. Biophys. Acta 1999; 1462: 55-70.
45. Bechinger B, Lohner K. Detergent-like action of linear cationic membrane-active antibiotic peptides. Biochim. Biophys. Acta 2006; 1758: 1529-1539.
46. Bechinger B. Rationalizing the membrane interactions of cationic amphipathic antimicrobial peptides by their molecular shape. Curr. Opin. Colloid Interface Sci. Surfact. 2009; 14: 349-355.
47. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005; 3: 238-250.
48. Nicolas P. Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides. FEBS J. 2009; 276: 6483-6496.
49. Bechinger B, Zasloff M, Opella SJ. Structure and dynamics of the antibiotic peptide PGLa in membranes by multidimensional solution and solid-state NMR spectroscopy. Biophys. J. 1998; 74: 981-987.
50. Matsuzaki K, Murase O, Tokuda H, Funakoshi S, Fujii N, Miyajima K. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry 1994; 33: 3342-3349.
51. Dathe M, Nikolenko H, Meyer J, Beyermann M, Bienert M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS. Lett. 2001; 501: 146-150.
52. Wieprecht T, Apostolov O, Seelig J. Binding of the antibacterial peptide magainin 2 amide to small and large unilamellar vesicles. Biophys. Chem. EDAT- 2000/08/29 MHDA- 2000/08/29 PST-ppublish. 2000; 85: 187-198.
53. Ludtke S, He K, Huang H. Membrane thinning caused by magainin 2. Biochemistry 1995; 34: 16764-16769.
54. Bechinger B, Kim Y, Chirlian LE, Gesell J, Neumann JM, Montal M, Tomich J, Zasloff M, Opella SJ. Orientations of amphipathic helical peptides in membrane bilayers determined by solid- state NMR spectroscopy. J. Biomol. NMR 1991; 1: 167-173.
55. Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 1992; 31: 12416-12423.
56. Ramamoorthy A, Thennarasu S, Lee DK, Tan A, Maloy L. Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. Biophys. J. 2006; 91: 206-216.
57. Strandberg E, Kanithasen N, Tiltak D, Burck J, Wadhwani P, Zwernemann O, Ulrich AS. Solid-state NMR analysis comparing the designer-made antibiotic MSI-103 with its parent peptide PGLa in lipid bilayers. Biochemistry 2008; 47: 2601-2616.
58. Mason AJ, Moussaoui W, Abdelrhaman T, Boukhari A, Bertani P, Marquette A, Shooshtarizaheh P, Moulay G, Boehm N, Guerold B, Sawers RJH, Kichler A, Metz-Boutigue MH, Candolfi E, Prevost G, Bechinger B. Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine rich amphipathic cationic peptides. J. Biol. Chem. 2009; 284: 119-133.
59. Verly RM, Moraes CM, Resende JM, Aisenbrey C, Bemquemer MP, Pilo-Veloso D, Valente AP, Alemida FC, Bechinger B. Structure and membrane interactions of the antibiotic peptide dermadistinctin k by solution and oriented 15 N and 31 P solid-state NMR spectroscopy. Biophys. J. 2009; 96: 2194-2202.
60. Resende JM, Mendonca Moraes C, Munhoz VHDO, Aisenbrey C, Verly RM, Bertani P, Cesar A, Pilo-Veloso D, Bechinger B. Membrane structure and conformational changes during bilayer-association of the antibiotic heterodimeric peptide distinctin by oriented solid-state NMR spectroscopy. Proc. Natl. Acad. Sci. U S A 2009; 106: 16639-16644.
61. Bechinger B, Resende JM, Aisenbrey C. The structural and topological analysis of membrane-associated polypeptides by oriented solid-state NMR spectroscopy: established concepts and novel developments. J. Biophys. Chem. 2010; doi:10.1016/j.bpc.2010.11.002.
62. Leontiadou H, Mark AE, Marrink SJ. Antimicrobial peptides in action. J. Am. Chem. Soc. 2006; 128: 12156-12161.
63. Bechinger B, Bertani P, Werten S, Mendonca de Moraes C, Aisenbrey C, Mason AJ, Perrone B, Prudhon M, Sudheendra US, Vidovic V, Miguel C. The structural and topological analysis of membrane polypeptides by oriented solid-state NMR spectroscopy: Sample preparation and theory. In Membrane-Active Peptides: Methods and Results on Structure and Function. La Jolla, California, USA: International University Line: 2010; 196-215.
64. Bechinger B, Sizun C. Alignment and structural analysis of membrane polypeptides by 15N and 31P solid-state NMR spectroscopy. Concepts. Magn. Reson. 2003; 18A: 130-145.
65. Bechinger B, Zasloff M, Opella SJ. Structure and interactions of magainin antibiotic peptides in lipid bilayers: a solid-state NMR investigation. Biophys. J. 1992; 62: 12-14.
66. Bechinger B, Zasloff M, Opella SJ. Structure and orientation of the antibiotic peptide magainin in membranes by solid-state NMR spectroscopy. Protein Sci. 1993; 2: 2077-2084.
67. Ramamoorthy A, Marassi FM, Zasloff M, Opella SJ. Three-dimensional solid-state NMR spectroscopy of a peptide oriented in membrane bilayers. J. Biomol. NMR 1995; 6: 329-334.
68. Bechinger B, Gierasch LM, Montal M, Zasloff M, Opella SJ. Orientations of helical peptides in membrane bilayers by solid-state NMR spectroscopy. Solid State Nucl. Magn. Reson. 1996; 7: 185-192.
69. Marassi FM, Opella SJ. A solid-state NMR index of helical membrane protein structure and topology. J. Magn. Reson. 2000; 144: 150-155.
70. Ludtke SJ, He K, Wu Y, Huang HW. Cooperative membrane insertation of maginin correlated with its cytolytic activity. Biochim. Biophys. Acta 1994; 1190: 181-184.
71. Strandberg E, Tremouilhac P, Wadhwani P, Ulrich AS. Synergistic transmembrane insertion of the heterodimeric PGLa/magainin 2 complex studied by solid-state NMR. Biochim. Biophys. Acta 2009; 1788: 1667-1679.
72. Glaser RW, Sachse C, Durr UH, Wadhwani P, Afonin S, Strandberg E, Ulrich AS. Concentration-dependent realignment of the antimicrobial peptide PGLa in lipid membranes observed by solid-state 19F-NMR. Biophys. J. 2005; 88: 3392-3397.
73. Tremouilhac P, Strandberg E, Wadhwani P, Ulrich AS. Conditions affecting the re-alignment of the antimicrobial peptide PGLa in membranes as monitored by solid state 2H-NMR. Biochim. Biophys. Acta 2006; 1758: 1330-1342.
74. Tremouilhac P, Strandberg E, Wadhwani P, Ulrich AS. Synergistic transmembrane alignment of the antimicrobial heterodimer PGLa/magainin. J. Biol. Chem. 2006; 281: 32089-32094.
75. Aisenbrey C, Bechinger B. Tilt and rotational pitch angles of membrane-inserted polypeptides from combined 15N and 2H solid-state NMR spectroscopy. Biochemistry 2004; 43: 10502-10512.
76. Raimondo D, Andreotti G, Saint N, Amodeo P, Renzone G, Sanseverino M, Zocchi I, Molle G, Motta A, Scaloni A. A folding-dependent mechanism of antimicrobial peptide resistance to degradation unveiled by solution structure of distinctin. Proc. Natl. Acad. Sci. U S A 2005; 102: 6309-6314.
77. Vogt TCB, Bechinger B. The interactions of histidine-containing amphipathic helical peptide antibiotics with lipid bilayers: the effects of charges and pH. J. Biol. Chem. 1999; 274: 29115-29121.
78. Bechinger B. Towards membrane protein design: pH dependent topology of histidine-containing polypeptides. J. Mol. Biol. 1996; 263: 768-775.
79. Bechinger B, Ruysschaert JM, Goormaghtigh E. Membrane helix orientation from linear dichroism of infrared attenuated total reflection spectra. Biophys. J. 1999; 76: 552-563.
80. Aisenbrey C, Kinder R, Goormaghtigh E, Ruysschaert JM, Bechinger B. Interactions involved in the realignment of membrane-associated helices: an investigation using oriented solid-state NMR and ATR-FTIR spectroscopies topologies. J. Biol. Chem. 2006; 281: 7708-7716.
81. Aisenbrey C, Goormaghtigh E, Ruysschaert JM, Bechinger B. Translocation of amino acyl residues from the membrane interface to the hydrophobic core: thermodynamic model and experimental analysis using ATR-FTIR spectroscopy. Mol. Membr. Biol. 2006; 23: 363-374.
82. Marquette A, Mason AJ, Bechinger B. Aggregation and membrane permeabilizing properties of designed histidine-containing cationic linear peptide antibiotics. J. Pept. Sci. 2008; 14: 488-495.
83. Mason AJ, Gasnier C, Kichler A, Prevost G, Aunis D, Metz-Boutigue MH, Bechinger B. Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH. Antimicrob. Agents Chemother. 2006; 50: 3305-3311.
84. Salnikov ES, Mason AJ, Bechinger B. Membrane order perturbation in the presence of antimicrobial peptides by 2 H solid-state NMR spectroscopy. Biochimie 2009; 91: 743.
85. Haney EF, Nathoo S, Vogel HJ, Prenner EJ. Induction of non-lamellar lipid phases by antimicrobial peptides: a potential link to mode of action. Chem. Phys. Lipids. 2010; 163: 82-93.
86. Lohner K, Prossnigg F. Biological activity and structural aspects of PGLa interaction with membrane mimetic systems. Biochim. Biophys. Acta 2009; 1788: 1656-1666.
87. Makovitzki A, Baram J, Shai Y. Antimicrobial lipopolypeptides composed of palmitoyl Di- and tricationic peptides: in vitro and in vivo activities, self-assembly to nanostructures, and a plausible mode of action. Biochemistry 2008; 47: 10630-10636.
88. Patch JA, Barron AE. Helical peptoid mimics of magainin-2 amide. J. Am. Chem. Soc. 2003; 125: 12092-12093.
89. Porter EA, Weisblum B, Gellman SH. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides. J. Am. Chem. Soc. 2002; 124: 7324-7330.
90. Kuroda K, DeGrado WF. Amphiphilic polymethacrylate derivatives as antimicrobial agents. J. Am. Chem. Soc. 2005; 127: 4128-4129.
91. Violette A, Fournel S, Lamour K, Chaloin O, Frisch B, Briand JP, Monteil H, Guichard G. Mimicking helical antibacterial peptides with nonpeptidic folding oligomers. Chem. Biol. 2006; 13: 531-538.
92. Palermo EF, Kuroda K. Structural determinants of antimicrobial activity in polymers which mimic host defense peptides. Appl. Microbiol. Biotechnol. 2010; 87: 1605-1615.
93. Scott RW, DeGrado WF, Tew GN. De novo designed synthetic mimics of antimicrobial peptides. Curr. Opin. Biotechnol. 2008; 19: 620-627.
94. Rotem S, Mor A. Antimicrobial peptide mimics for improved therapeutic properties. Biochim. Biophys. Acta 2009; 1788: 1582-1592.
95. Wenk M, Seelig J. Magainin 2 amide interaction with lipid membranes: calorimetric detection of peptide binding and pore formation. Biochemistry 1998; 37: 3909-3916.
96. Bechinger B. Membrane-lytic peptides. CRC Crit. Rev. Plant. Sci. 2004; 23: 271-292.
97. Lohner K. New strategies for novel antibiotics: peptides targeting bacterial cell membranes. Gen. Physiol. Biophys. 2009; 28: 105-116.
98. Matsuzaki K, Harada M, Funakoshi S, Fujii N, Miyajima K. Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim. Biophys. Acta 1991; 1063: 162-170.
99. Klocek G, Seelig J. Melittin interaction with sulfated cell surface sugars. Biochemistry 2008; 47: 2841-2849.
100. Bechinger B. Detergent-like properties of magainin antibiotic peptides: a 31P solid-state NMR study. Biochim. Biophys. Acta 2005; 1712: 101-108.
101. Bechinger B. Membrane insertion and orientation of polyalanine peptides: a 15 N solid-state NMR spectroscopy investigation. Biophys. J. 2001; 82: 2251-2256.
102. Aisenbrey C, Sudheendra US, Ridley H, Bertani P, Marquette A, Nedelkina S, Lakey JH, Bechinger B. Helix orientations in membrane-associated Bcl-X L determined by 15 N solid-state NMR spectroscopy. Eur. Biophys. J. 2007; 36: 451-460.
103. Sudheendra US, Bechinger B. Topological equilibria of ion channel peptides in oriented lipid bilayers revealed by 15N solid-state NMR spectroscopy. Biochemistry 2005; 44: 12120-12127.
104. Salnikov E, Aisenbrey C, Vidovic V, Bechinger B. Solid-state NMR approaches to measure topological equilibria and dynamics of membrane polypeptides. Biochim. Biophys. Acta 2010; 1798: 258-265.
105. Schwarz G, Stankowski S, Rizzo V. Thermodynamic analysis of incorporation and aggregation in a membrane: application to the pore-forming peptide alamethicin. Biochim. Biophys. Acta 1986; 861: 141-151.
106. Sansom MSP. The biophysics of peptide models of ion channels. Prog. Biophys. Mol. Biol. 1991; 55: 139-235.
107. White SH, Wimley WC. Membrane protein folding and stability: physical principles. Annu. Rev. Biophys. Biomol. Struct. 1999; 28: 319-365.
108. Bechinger B. Membrane association and pore formation by alpha-helical peptides. Adv. Exp. Med. Biol. 2010; 677: 24-30.
109. Huang HW, Wu Y. Lipid-alamethicin interactions influence alamethicin orientation. Biophys. J. 1991; 60: 1079-1087.
110. Huang HW. Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim. Biophys. Acta 2006; 1758: 1292-1302.
111. Leitgeb B, Szekeres A, Manczinger L, Vagvolgyi C, Kredics L. The history of alamethicin: a review of the most extensively studied peptaibol. Chem. Biodivers. 2007; 4: 1027-1051.
112. North CL, Barranger-Mathys M, Cafiso DS. Membrane orientation of the N-terminal segment of alamethicin determined by solid-state 15 N NMR. Biophys. J. 1995; 69: 2392-2397.
113. Bak M, Bywater RP, Hohwy M, Thomsen JK, Adelhorst K, Jakobsen HJ, Sorensen OW, Nielsen NC. Conformation of alamethicin in oriented phospholipid bilayers determined by N-15 solid-state nuclear magnetic resonance. Biophys. J. 2001; 81: 1684-1698.
114. Salnikov ES, Friedrich H, Li X, Bertani P, Reissmann S, Hertweck C, O'Neil JD, Raap J, Bechinger B. Structure and alignment of the membrane-associated peptaibols ampullosporin A and alamethicin by oriented 15 N and 31 P solid-state NMR spectroscopy. Biophys. J. 2009; 96: 86-100.
115. Huang HW. Action of antimicrobial peptides: Two-state model. Biochemistry 2000; 39: 8347-8452.
116. Bechinger B, Skladnev DA, Ogrel A, Li X, Swischewa NV, Ovchinnikova TV, O'Neil JDJ, Raap J. 15 N and 31 P solid-state NMR investigations on the orientation of zervamicin II and alamethicin in phosphatidylcholine membranes. Biochemistry 2001; 40: 9428-9437.
117. Westerhoff HV, Zasloff M, Rosner JL, Hendler RW, de Waal A, Vaz G, Jongsma PM, Riethorst A, Juretic D. Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes. Eur. J. Biochem. 1995; 228: 257-264.
118. Matsuzaki K, Mitani Y, Akada K, Murase O, Yoneyama S, Zasloff M, Miyajima K. Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry 1998; 37: 15144-15153.
119. Oren Z, Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 1998; 47: 451-463.
120. Bashford CL, Alder GM, Menestrina G, Micklem KJ, Murphy JJ, Pasternack JA. Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents. J. Biol. Chem. 1986; 261: 9300-9308.
121. Cassone M, Otvos L Jr. Synergy among antibacterial peptides and between peptides and small-molecule antibiotics. Expert Rev. Anti. Infect. Ther. 2010; 8: 703-716.
122. Morris MC, Chaloin L, Mery J, Heitz F, Divita G. A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucl. Acids Res. 1999; 27: 3510-3517.
123. Kichler A, Pages JC, Leborgne C, Druillennec S, Lenoir Coulaud D, Delain E, Le Cam E, Roques BP, Danos O. Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R. J. Virol. 2000; 74: 5424-5431.
124. Kichler A, Leborgne C, MÑrz J, Danos O, Bechinger B. Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc. Natl. Acad. Sci. U S A 2003; 100: 1564-1568.
125. Langlet-Bertin B, Leborgne C, Scherman D, Bechinger B, Mason AJ, Kichler A. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery. Pharm. Res. 2010; 27: 1426-1436.
126. Bechinger B, Vidovic V, Bertani P, Kichler A. A new family of peptide-nucleic acid nanostructures with potent transfection activities. J. Pept. Sci. (In press) 2010.
127. Prongidi-Fix L, Sugewara M, Bertani P, Raya J, Leborgne C, Kichler A, Bechinger B. Self-promoted uptake of peptide/DNA transfection complexes. Biochemistry 2007; 46: 11253-11262.
128. Mason AJ, Martinez A, Glaubitz C, Danos O, Kichler A, Bechinger B. The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes. FASEB J. 2006; 20: 320-322.
129. Mason AJ, Bechinger B, Kichler A. Rational design of vector and antibiotic peptides using solid-state NMR. Mini. Rev. Med. Chem. 2007; 7: 491-497.
130. Mason AJ, Leborgne C, Moulay G, Martinez A, Danos O, Bechinger B, Kichler A. Optimising histidine rich peptides for efficient DNA delivery in the presence of serum. J. Control. Release 2007; 118: 95-104.
131. Marquette A, Lorber B, Bechinger B. Reversible liposome association induced by LAH4: a peptide with potent antimicrobial and nucleic acid transfection activities. Biophys. J 2010; 98: 2544-2553.
132. Jung S, Dingley AJ, Augustin R, Anton-Erxleben F, Stanisak M, Gelhaus C, Gutsmann T, Hammer MU, Podschun R, Bonvin AM, Leippe M, Bosch TC, Grotzinger J. Hydramacin-1, structure and antibacterial activity of a protein from the basal metazoan Hydra. J. Biol. Chem. 2009; 284: 1896-1905.
133. Zhao X, Pan F, Xu H, Yaseen M, Shan H, Hauser CA, Zhang S, Lu JR. Molecular self-assembly and applications of designer peptide amphiphiles. Chem. Soc. Rev. 2010; 39: 3480-3498.